Approved Shell
========================
+ 1. Drug: 
 + 2. Model:
 + 3. Model params
 + 4. Dosing regimen (bolus)
 + 5. Dosing regimen (infusion)
 + 6. Dosing regimen (multiple dosing of 4 with Tau = )
 + 7. Population PK - CV% of model params
 + 8. Correlates 
 + 9.  PD
 
JP's proposition: Revilla et al. 
==========================
 + 1. Drug: Vanco 
 + 2. Model: 1CMPT
 + 3. Params(extrapolated): CL = 5.1L/hr; v1 = 59.86 L
 + 4. Dosing regimen (bolus) : 1g q12h 
 + 5. Dosing regimen (infusion) : 1 g q12h over 1h 
 + 6. Dosing regimen multiple strategies: 1g q12, 0.5g q6h
 + 7. Population PK - CV of params: CL 30.13%; V1 22.83%
 + 8. Correlates: CL(ml/min/kg) = 0.67 * CrCl + AGE^.24; V1 invariant
 + 9. Population average CL/Age in study: 61.1(sd = 16.3) y, CL = 86.1(sd = 55.1) mL/min
 
JP's proposition 2:  Yasuhara et al.
=============================
 + 1. Drug: Vanco 
 + 2. Model: **2** CMPT
 + 3. Params(extrapolated): CL = 3.68/hr; vss = 60.7; k12: .525, k32: .213
 + 4. Dosing regimen (bolus) : 1g q12h 
 + 5. Dosing regimen (infusion) : 1 g q12h over 1h 
 + 6. Dosing regimen multiple strategies: 1g q12, 0.5g q6h
 + 7. Population PK - CV of params: CL 38.5, K1`2 Fixed, K21 28.6, Vss 25.4
 + 8. Correlates: CL(ml/min/kg) = CL(L/h) = .0478 * CrCL
 + 9. Population average CL/Age in study: 77.1(sd 50.9) 
 
###discussion - 
1st study is simpler model (1COMP), but has more complex covariates.
2nd study has simpler covariates but more complicated model. 


Citation:
Predictive performance of reported population pharmacokinetic models of
vancomycin in Chinese adult patients, J. Clin Pharm & Ther, 2013, 38, 480-489 (a review of 11 models)
